| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 208.84B | 224.32B | 207.17B | 187.46B | 191.08B | 191.25B |
| Gross Profit | 52.20B | 57.70B | 51.68B | 46.54B | 42.35B | 40.21B |
| EBITDA | 20.53B | 22.44B | 20.69B | 18.39B | 15.31B | 14.36B |
| Net Income | 13.95B | 14.66B | 14.05B | 12.20B | 9.60B | 9.28B |
Balance Sheet | ||||||
| Total Assets | 128.60B | 146.18B | 134.18B | 120.73B | 102.25B | 95.30B |
| Cash, Cash Equivalents and Short-Term Investments | 51.45B | 53.30B | 57.73B | 48.52B | 41.14B | 24.57B |
| Total Debt | 14.39B | 14.05B | 13.80B | 15.43B | 10.22B | 12.71B |
| Total Liabilities | 41.51B | 45.63B | 44.66B | 41.38B | 33.95B | 36.01B |
| Stockholders Equity | 86.89B | 100.32B | 89.32B | 79.18B | 67.22B | 58.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.29B | 16.08B | 5.44B | 21.61B | -7.77B |
| Operating Cash Flow | 0.00 | 3.44B | 17.59B | 8.20B | 24.02B | -6.76B |
| Investing Cash Flow | 0.00 | -4.48B | -24.83B | -6.20B | -2.74B | -1.19B |
| Financing Cash Flow | 0.00 | -9.09B | -8.12B | -132.00M | -5.81B | 224.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥98.58B | 4.62 | ― | 4.76% | 1.01% | 79.22% | |
78 Outperform | ¥148.97B | 6.16 | 12.77% | 2.84% | 11.98% | 115.65% | |
70 Outperform | ¥59.24B | 7.43 | ― | 2.03% | -18.06% | 64.88% | |
65 Neutral | ¥214.32B | 14.94 | ― | 2.70% | 8.28% | 7.21% | |
64 Neutral | ¥804.49B | -8.91 | 6.07% | 3.69% | 3.69% | -66.27% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥4.08T | 19.73 | ― | 3.27% | 1.75% | 93.78% |